$18.2 Million is the total value of ISZO CAPITAL MANAGEMENT LP's 3 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 114.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CO | Exit | GLOBAL CORD BLOOD CORPORATIO | $0 | – | -279,495 | -100.0% | 0.00% | – |
FRC | Exit | FIRST REP BK SAN FRANCISCO C | $0 | – | -52,000 | -100.0% | -3.87% | – |
SPY | Exit | SPDR S&P 500 ETF TRtr unit | $0 | – | -2,500 | -100.0% | -5.44% | – |
NVO | Exit | NOVO-NORDISK A Sadr | $0 | – | -7,000 | -100.0% | -5.92% | – |
QQQ | Exit | INVESCO QQQ TRunit ser 1 | $0 | – | -4,800 | -100.0% | -8.19% | – |
UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -9,000 | -100.0% | -10.72% | – |
NVS | Exit | NOVARTIS AGsponsored adr | $0 | – | -22,000 | -100.0% | -10.76% | – |
Exit | CBL & ASSOC PPTYS INC | $0 | – | -82,081 | -100.0% | -11.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NAM TAI PPTY INC | 16 | Q3 2022 | 60.5% |
AVID BIOSERVICES INC | 13 | Q4 2021 | 46.6% |
XPEL INC | 10 | Q4 2021 | 22.3% |
TARO PHARMACEUTICALS INDUS LTD | 8 | Q4 2015 | 85.7% |
AMERCO | 8 | Q4 2015 | 11.2% |
NATHANS FAMOUS INC NEW | 7 | Q1 2017 | 68.9% |
MMA CAP MGMT LLC | 7 | Q1 2017 | 17.8% |
CBL & ASSOC PPTYS INC | 6 | Q3 2023 | 95.2% |
LIFECORE BIOMEDICAL INC | 6 | Q4 2022 | 35.1% |
CRYO-CELL INTL INC | 6 | Q4 2022 | 11.0% |
View ISZO CAPITAL MANAGEMENT LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-12 |
View ISZO CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.